Black patients with pulmonary arterial hypertension tend to experience diagnostic delays and have more severe disease, a U.S.

Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary ...

A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving ...

Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...

Columnist Jolie Lizana is not just happy to take a day of rest for National Relaxation Day; she contends that such rest is ...

Immune cell metabolism changes may underlie PAH inflammation, which could inform targets for new PAH treatment strategies.

Pulmonary hypertension (PH) is a rare, serious disease characterized by high blood pressure and damaged pulmonary arteries. These vessels, which are responsible for carrying the blood from the right ...

After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...

To reduce fatigue, the first thing columnist Jen Cueva did was analyze her sleep patterns, revealing some surprising results.

Having PH increases the risk of death in both the short and long term when undergoing surgery for aortic stenosis, a heart valve disease.

Increasing irisin, found at lower levels in people with PAH, may help slow disease progression by stopping vascular remodeling, per a study.